Spironolactone: An Anti-Androgenic and Anti-Hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19

    July 2020 in “ Frontiers in Medicine
    Flavio Cadegiani, Carlos Gustavo Wambier, Andy Goren
    New to Spironolactone? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary Spironolactone might help protect against severe lung problems in COVID-19 patients.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results